foxyliam/AdobeStock.com
healing ways
High Times for the Cannabis Industry Emerging Trends with a COVID-19 Caveat by Jim Motavalli
I
t’s fair to say that the cannabis industry has arrived. Recreational marijuana has now been approved in 17 states, and 37 have allowed marijuana for medical purposes. “We have CBD!” proclaim store signs selling the buzz-free cannabidiol. In 2020, more than 240,000 people worked in cannabis-related jobs. The Brightfield Group says the medical cannabis industry will reach $16 billion in annual U.S. sales by 2025. Cannabis market research firm Headset predicts this will be “a year of positive growth” for the industry. Legalization and expansion are strongly in line with public sentiment: Two-thirds of Americans believe marijuana should be legal, says the Pew Research Center. Opposition has fallen from 52 percent in 2010 to just 32 percent by the end of 2019. “Dispensaries and cannabis cafés are as commonplace as Starbucks, and ordering edibles is as easy as getting pizza,” reports marketing firm Grassfed Media. The National Retail Federation 18
Inland Northwest
inwAwakenings.com
noted a 700 percent increase in the demand for CBD-based products in 2019. One caveat, however, is COVID-19. Ron Newman, a sustainable development analyst with Lee Enterprises Consulting, says the hemp/CBD business was flat during 2020 because of the pandemic. “With the economic situation, people were buying only essentials,” he says. “But we’re seeing the business start to come back now.” With COVID-19 recovery, more growth is certain, and here are some upcoming trends. Tetrahydrocannabinol (THC) is the active ingredient in marijuana that gets the user high. The natural compound CBD—said to have healing and pain/anxiety relief properties—is being heavily marketed in the form of oils, edibles (including gummy bears and lollipops), oral sprays, creams and pills. The third-most popular food-related Google search term in 2018 was “CBD gummies”. CBD dietary supplements are the biggest category, followed by
